PHARMACYTE BIOTECH, INC. Unrealized Gain (Loss) on Derivatives
PHARMACYTE BIOTECH, INC. (PMCB) reported Unrealized Gain (Loss) on Derivatives of $0 for the 3-month period ending 2015-10-31, per its 10-Q/A filed 2016-01-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2016-01-19
- PHARMACYTE BIOTECH, INC. unrealized gain (loss) on derivatives for the quarter ending 2015-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. unrealized gain (loss) on derivatives for the quarter ending 2015-07-31 was $462.30K.
- PHARMACYTE BIOTECH, INC. unrealized gain (loss) on derivatives for the quarter ending 2014-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. unrealized gain (loss) on derivatives for the quarter ending 2014-07-31 was $0.00.
- PHARMACYTE BIOTECH, INC. unrealized gain (loss) on derivatives for fiscal 2015 was $0.00.
- PHARMACYTE BIOTECH, INC. unrealized gain (loss) on derivatives for fiscal 2014 was $0.00.
- PHARMACYTE BIOTECH, INC. unrealized gain (loss) on derivatives for fiscal 2013 was $0.00.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 3 month as first filed | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 6 month as first filed | Unrealized Gain (Loss) on Derivatives 12 month | Unrealized Gain (Loss) on Derivatives 12 month as first filed |
|---|---|---|---|---|---|---|
| 2015-10-31 | $0.00 10-Q/A · filed 2016-01-19 | $29.75K 10-Q · filed 2015-12-10 | $0.00 10-Q/A · filed 2016-01-19 | $492.05K 10-Q · filed 2015-12-10 | ||
| 2015-07-31 | $462.30K 10-Q · filed 2015-08-25 | |||||
| 2015-04-30 | $0.00 10-K/A · filed 2016-01-19 | -$492.05K 10-K · filed 2015-07-29 | ||||
| 2014-10-31 | $0.00 10-Q · filed 2015-12-10 | $0.00 10-Q · filed 2015-12-10 | ||||
| 2014-07-31 | $0.00 10-Q · filed 2015-08-25 | |||||
| 2014-04-30 | $0.00 10-K · filed 2015-07-29 | |||||
| 2013-04-30 | $0.00 10-K · filed 2015-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |